Becton Dickinson & Co: (NYSE: BDX)

$100.17

0.15 (0.15%)

Volume 624,910

May 23 04:01 PM ET

Zacks Rank: 2-Buy

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		99.24 - 100.57
	
		52wk Low - High
		71.56 - 102.73
	
		Previous Close
		100.02
	
		Avg. Volume
		1,104,148
	
		Industry
		MED/DENTAL-SUPP
	
		Market Cap
		19.40 B
	
		Div - Yield
		1.98 - 1.98
	
		Beta
		0.68
	
		PE (Forward)
		17.41
	
		Current Year Est.
		5.74
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		2
Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		121 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/6/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            17.41
                        
                            PEG Ratio
                            2.24
                        
                            Current Year Est.
                            5.74
                        
                            Current Quarter Estimate
                            1.48
                        
                            Most Accurate Estimate
                            1.48
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-08-2013
                        
                            EPS Last Year
                            5.73
                        
                            Expected Earnings Growth
                            7.78%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public.  BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.   
Full BDX Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
BDX Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (09/2013)	Next Year (09/2014)
Average Estimate	1.48	1.52	5.74	6.26
Number of Estimates	13	12	16	13
Low Estimate	1.46	1.50	5.73	6.19
High Estimate	1.53	1.54	5.77	NA
Year Ago EPS	1.52	1.42	5.37	5.74
EPS Growth	-2.63%	7.34%	6.96%	9.04%

More BDX Estimates

Average Earnings Estimates for BDX

EPS Growth for BDX

Industry Analysis

Name	Symbol	Previous Close
BECTON DICKINSO	BDX	100.02
LUXOTTICA ADR	LUX	54.12
ALPHATEC HLDGS	ATEC	1.91
CONMED CORP	CNMD	33.28
COOPER COS	COO	107.22
STERIS CORP	STE	45.03
WEST PHARM SVC	WST	67.34
ALIGN TECH INC	ALGN	37.30
BARD C R INC	BCR	105.28
BIO REFERNC LAB	BRLI	31.07

Sector:Medical>> Industry:MED/DENTAL-SUPP

COMPARE TICKER vs. Its Peers

Zacks Commentary

Patterson Cos Posts In-Line Earnings

May 23, 2013

BSX Entangled in Patent Issues

May 22, 2013

Wright Medical Stays Neutral

May 22, 2013

THOR Downgraded to Underperform

May 21, 2013

FDA Nod for Thoratec Controller

May 20, 2013

PKI Downgraded to Underperform

May 20, 2013

Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co.

May 16, 2013

Alere Beats Earnings Est, Turns to Profit

May 10, 2013

More BDX Zacks Commentary

Financials

EPS TTM	5.73
Sales	7,708
Net Income	1,517
Price/Earnings	17.45
Price/Book	4.23
Price/Cash Flow	12.22
Price/Sales	2.47

More BDX Financials

News

BD Issues 2012 Sustainability Report - Pr Newswire

May 22, 2013

BD's board announces dividend to holders of record on 7 June 2013 - M2

May 22, 2013

Becton Dickinson: The Winning Streak Continues (BDX) - Financial News Netwfork Online - 52-Week High-Lows

May 22, 2013

Bullish Moving Average Cross by Becton Dickinson (BDX) - Financial News Network Online - Moving Average Crossovers

May 22, 2013

BD Board Declares Dividend - Pr Newswire

May 21, 2013

Post Earnings Update: Becton Dickinson Has Climbed 5.8% Higher in Past 2 Weeks (BDX) - Comtex Smartrend(R)

May 20, 2013

Post Earnings Update: Becton Dickinson Has Climbed 5.8% Higher in Past 2 Weeks (BDX) - Financial News Network Online - Earnings Lookback

May 18, 2013

5 Healthcare Stocks With The Highest EPS - Benzinga

May 14, 2013

See All News Stories on BDX

Broker Recommendations

Current ABR	3.06
ABR (Last Week)	3.06
# of recs in ABR	17
Average Target Price	90.50
Industry Rank by ABR	121 out of 265
Rank in Industry	2 out of 29

More BDX Broker Recommendations

Day Low - High	99.24 - 100.57
52wk Low - High	71.56 - 102.73
Previous Close	100.02
Avg. Volume	1,104,148
Industry	MED/DENTAL-SUPP
Market Cap	19.40 B
Div - Yield	1.98 - 1.98
Beta	0.68
PE (Forward)	17.41
Current Year Est.	5.74
Quarterly Earnings ESP	0.00%

PE (Forward)	17.41
PEG Ratio	2.24
Current Year Est.	5.74
Current Quarter Estimate	1.48
Most Accurate Estimate	1.48
Earnings ESP	0.00%
Next Earnings Report Date	08-08-2013
EPS Last Year	5.73
Expected Earnings Growth	7.78%

Username: Password:

Remember me [?]

Becton Dickinson & Co: (NYSE: BDX)

$100.17

0.15 (0.15%)

Volume 624,910

May 23 04:01 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED/DENTAL-SUPP

Zacks Commentary

Financials

News

Broker Recommendations